Latest News

GeoVax Awarded NIH Grant for Novel Zika Vaccine
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today ...
Continue Reading...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7
CEO Robert McNally to Speak as part of BIO’s One Health Day Program GeoVax Labs, Inc. (OTCQB: GOVX)...
Continue Reading...
GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced ...
Continue Reading...